Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB for VATS
NCT03628040Phase 3Unknown
- Start
- Sep 2019
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms). Primary endpoint: Opioid consumption in IV morphine equivalents at 24 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03628040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03628040.